Intriguingly, CAD is also associated with unfavorable survival in liver cancer and renal cancer [13], and it catalyzes the rate-limiting step of the de novo PS pathway [14], suggesting it may be expressed at higher levels than DHODH and UMPS in de novo PS to ameliorate chemotherapy induced genotoxic damage. This evidence concerns the gene UMPS and liver cancer.